CANF
Can-fite Biopharma·AMEX
--
--(--)
--
--(--)
3.62 / 10
Netural
Fund flow is good (7.24/10) but trends negative; inflow ratios hover around 0.49. Sentiment is neutral. Analysts are unanimously Strong‑Buy, yet their historical win rate is 0% with negative returns, making the endorsement unreliable.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-17
InstitutionD. Boral Capital
Times predicted6
Historical Win Rate0.0%
Is money flowing into or out of CANF?
- CANF holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.62/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
